GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders
Lorenzo Leggio, Christian S. Hendershot, Mehdi Farokhnia, Anders Fink‐Jensen, Mette Kruse Klausen, Joseph P. Schacht, W. Kyle Simmons
Topics & Concepts
Alcohol use disorderAlcoholMedicinePharmacologyReceptorClinical trialGlucagon-like peptide 1 receptorSubstance useAgonistInternal medicinePsychiatryChemistryBiochemistryPharmacology and Obesity TreatmentDiabetes Treatment and ManagementAlcohol Consumption and Health Effects